News ArticleInventurus Knowledge Solutions Reports Q2 FY27 Investor Presentation Highlighting AI-Driven Growth and Platform Innovation
The presentation details client metrics, strategic initiatives, and technology integration as of September 30, 2026
Inventurus Knowledge Solutions Limited released its investor presentation for Q2 FY27 detailing its AI-driven healthcare enablement platform, strategic pillars for growth, key partnerships, and technological advances. The presentation outlines company metrics as of September 30, 2026, including client base, employee strength, and market size, alongside future business priorities and operational highlights.
Inventurus Knowledge Solutions Limited
Investor Presentation
Inventurus Knowledge Solutions Limited disclosed its investor presentation for the quarter and half-year ended September 30, 2026, emphasizing advancements in its AI-powered healthcare enablement platform, strategic execution plans, and ongoing partnerships to drive growth and optimize margins.
As of September 30, 2026, Inventurus serves over 31,900 healthcare organizations with a specialized workforce including 2,226 clinically trained staff among 16,318 employees. Their total addressable market is valued at US$260 billion with an outsourced market size of US$34 billion, featuring growth rates of 8% and 12% respectively from 2023 to 2028.
The company highlights its platform’s capabilities integrating System of Record (EHR) with a proprietary System of Action powered by AI to optimize workflows, enable automation, and improve clinical and financial outcomes across the patient journey.
Inventurus outlined five strategic pillars focused on developing AI-driven proprietary models, expanding integrated platforms across healthcare settings, increasing market penetration within large health systems, acquiring operational synergies, and strengthening culture and leadership.
Key technology initiatives include embedding explainable AI-driven workflows, API integrations with major EHR systems, and enhancing autonomous coding and denial prediction systems to reduce manual effort and improve revenue cycle management (RCM) efficiency.
Recent client wins include partnerships with White-Wilson Medical Center for comprehensive RCM and scheduling services, Augusta Health for EHR data migration and upcoming coverage verification support, and Evolve Orthopedic Partners deploying IKS Health’s intelligent patient access platform MyCareHub to transform front-end operations.
Highlights
- Over 31,900 healthcare organizations served as of Sept 30, 2026
- 16,318 employees including 2,226 clinically trained staff
- US$260 billion total addressable market with US$34 billion outsourced market
- 90%+ revenues from repeat customers over five years
- Five strategic execution pillars emphasizing AI-enabled workflows and platform integration
- Key deals with White-Wilson Medical Center, Augusta Health, and Evolve Orthopedic Partners
Key Data Snapshot
What happened
- Inventurus Knowledge Solutions Limited released its investor presentation covering Q2 and half year ended September 30, 2026.
- The presentation focuses on the company’s AI-driven healthcare enablement platform and strategic growth initiatives.
- Key client metrics, workforce composition, and market opportunities were highlighted alongside technology and operational updates.
Key details
- Serving over 31,900 healthcare organizations with more than 16,000 employees including over 2,200 clinically trained staff.
- Total addressable market valued at US$260 billion with an outsourced market of US$34 billion as per 2023 data.
- 90%+ of revenues derive from repeat customers with long-standing client relationships averaging over five years.
Strategic context
- Five strategic pillars include AI-powered proprietary workflow models, integrated platform expansion, growth in large health systems, operational synergies, and culture enhancement.
- The platform integrates System of Record (EHR) with a System of Action using AI, including explainable Generative AI, HITL oversight, and API integrations with leading health records.
- Focus on reducing manual effort in revenue cycle management via autonomous coding, denial prediction, and workflow automation to enhance provider productivity.
Transaction details
- Recent partnerships include White-Wilson Medical Center for full RCM and scheduling services including clinical support and value-based care.
- Augusta Health engagements include EHR data migration and potential expansion into coverage verification and RCM in new EMR workflows.
- Evolve Orthopedic Partners is implementing the MyCareHub patient access platform to advance specialty practice front-end operations.
Highlights
- Over 31,900 healthcare organizations served as of Sept 30, 2026
- 16,318 employees including 2,226 clinically trained staff
- US$260 billion total addressable market with US$34 billion outsourced market
- 90%+ revenues from repeat customers over five years
- Five strategic execution pillars emphasizing AI-enabled workflows and platform integration
- Key deals with White-Wilson Medical Center, Augusta Health, and Evolve Orthopedic Partners
Disclosures
- SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
More News on Investor Presentation
View allLatest corporate announcements and market updates in Investor Presentation.
Rubicon Research Limited Reports Nearly 40% Revenue Growth and 68% Profit Increase in Q2 FY26-27
Rubicon Research Limited posted significant financial growth for the quarter ended September 30, 2026, with revenue increasing by 39.9% year-on-year to ₹5,764 million and profit after tax rising 67.9% to ₹904 million. This performance includes the consolidation impact of its recent Arinna acquisition and reflects strong operational cash flows and product approvals.
Read Full Story
Sai Life Sciences Reports 23% Revenue Growth in Q2 FY27 with ₹659 Crore Revenue Amid Strategic Expansion
Sai Life Sciences Limited announced a 23% year-over-year revenue growth to ₹659 crore for the second quarter of fiscal year 2027, supported by healthy performance in both its Contract Research (CRO) and Contract Development and Manufacturing Organization (CDMO) segments. The company reported an EBITDA margin of 28% and continued its capital expenditure with ₹621 crore invested in the first half of FY27 to expand capacity and capabilities.
Read Full Story
Sterlite Technologies to Attend 29th CITIC CLSA India Forum and Host Plant Visit for Analysts in November 2026
Sterlite Technologies Limited will participate in the 29th CITIC CLSA India Forum on November 17, 2026, and conduct a plant visit for analysts and institutional investors on November 19, 2026, both events organized by Credit Lyonnais Securities Asia.
Read Full Story
